BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 10644991)

  • 1. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
    Summy JM; Guappone AC; Sudol M; Flynn DC
    Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src.
    Summy JM; Qian Y; Jiang BH; Guappone-Koay A; Gatesman A; Shi X; Flynn DC
    J Cell Sci; 2003 Jun; 116(Pt 12):2585-98. PubMed ID: 12734402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
    Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric constructs containing the SH4/Unique domains of cYes can restrict the ability of Src(527F) to upregulate heme oxygenase-1 expression efficiently.
    Hoey JG; Summy J; Flynn DC
    Cell Signal; 2000 Oct; 12(9-10):691-701. PubMed ID: 11080622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the SH3 domain in Ca2+-mediated regulation of Src family kinases.
    Monteiro AN
    Biochimie; 2006 Jul; 88(7):905-11. PubMed ID: 16546311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn.
    Ishino M; Ohba T; Sasaki H; Sasaki T
    Oncogene; 1995 Dec; 11(11):2331-8. PubMed ID: 8570184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Src association with and phosphorylation of p58gag, a membrane- and microfilament-associated retroviral Gag-like protein in a xenotransplantable rat mammary tumor.
    Huang J; Zhang BT; Li Y; Mayer B; Carraway KL; Carraway CA
    Oncogene; 1999 Jul; 18(28):4099-107. PubMed ID: 10435591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
    Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
    Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases.
    Baisden JM; Gatesman AS; Cherezova L; Jiang BH; Flynn DC
    Oncogene; 2001 Oct; 20(45):6607-16. PubMed ID: 11641786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src can regulate carboxy terminal interactions with AFAP-110, which influence self-association, cell localization and actin filament integrity.
    Qian Y; Baisden JM; Westin EH; Guappone AC; Koay TC; Flynn DC
    Oncogene; 1998 Apr; 16(17):2185-95. PubMed ID: 9619827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of the phosphorylation states of pp60c-src with tyrosine kinase activity: the intramolecular pY530-SH2 complex retains significant activity if Y419 is phosphorylated.
    Boerner RJ; Kassel DB; Barker SC; Ellis B; DeLacy P; Knight WB
    Biochemistry; 1996 Jul; 35(29):9519-25. PubMed ID: 8755732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain.
    Liu X; Brodeur SR; Gish G; Songyang Z; Cantley LC; Laudano AP; Pawson T
    Oncogene; 1993 May; 8(5):1119-26. PubMed ID: 7683128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product.
    Sudol M
    Oncogene; 1994 Aug; 9(8):2145-52. PubMed ID: 8035999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo.
    Lerner EC; Smithgall TE
    Nat Struct Biol; 2002 May; 9(5):365-9. PubMed ID: 11976726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for SH3 domain directed binding and phosphorylation of Sam68 by Src.
    Shen Z; Batzer A; Koehler JA; Polakis P; Schlessinger J; Lydon NB; Moran MF
    Oncogene; 1999 Aug; 18(33):4647-53. PubMed ID: 10467411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
    Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
    Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signalling by the p60c-src family of protein-tyrosine kinases.
    Kefalas P; Brown TR; Brickell PM
    Int J Biochem Cell Biol; 1995 Jun; 27(6):551-63. PubMed ID: 7545532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function relationships in Src family and related protein tyrosine kinases.
    Superti-Furga G; Courtneidge SA
    Bioessays; 1995 Apr; 17(4):321-30. PubMed ID: 7537961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF-2 facilitates binding of SH3 domain of PLC-gamma1 to vinculin and SH2 domains to FGF receptor in corneal endothelial cells.
    Park SY; Barron E; Suh PG; Ryu SH; Kay EP
    Mol Vis; 1999 Aug; 5():18. PubMed ID: 10459043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.